eXeBlock arranges $2.4-million private placement

Executive Summary

• eXeBlock Technology Corp. has arranged a non-brokered private placement of subscription receipts to raise up to $2.4 million CAD, concurrent with its proposed acquisition of Aitenders.
• The transaction is expected to constitute a "fundamental change" under Canadian Securities Exchange Policy 8, resulting in a trading halt for eXeBlock shares until the transaction completes.
• Subscription receipts will convert into common shares of the resulting issuer, Aitenders Technologies Inc., upon satisfaction of escrow release conditions, with gross proceeds held in escrow pending completion.

Key Details

• Financing Structure: Non-brokered private placement of subscription receipts.
• Gross Proceeds: Up to $2.4 million CAD.
• Price: 58.33 cents per subscription receipt.
• Transaction Context: Financing is concurrent with the proposed share acquisition of Aitenders, announced on Dec. 23, 2025.
• Conversion Terms: Each subscription receipt automatically converts into one common share of Aitenders Technologies Inc. for no further consideration, without action by holders, upon satisfaction of escrow release conditions.
• Escrow Arrangement: Gross proceeds held in escrow by the subscription receipt agent. If conditions are not satisfied or waived within the specified period, proceeds are returned to subscribers.
• Agent Compensation:
  • Agent: Numus Capital Corp. (registered exempt market dealer).
  • Cash Fee: 7% of proceeds raised.
  • Compensation Warrants: Issued to the agent, entitling them to purchase shares equal to 7% of the subscription receipts from investors introduced by the agent.
  • Warrant Exercise Price: 58.33 cents per share.
  • Warrant Term: 24 months from closing.
• Regulatory Status:
  • Transaction constitutes a fundamental change per CSE Policy 8.
  • Shares of eXeBlock are halted from trading until determined by the exchange (likely until transaction completion).
  • Securities issued are subject to a four-month-and-one-day hold period.
  • Subject to necessary approvals, including exchange approval.

Notable Quotes

• None provided in the text.